Daulton Varsho’s injury picture has changed the way his 2026 season looks, and it also makes the Toronto Blue Jays’ trade deadline deal with the Houston Astros look even more remarkable.
Varsho, 30, underwent left arthroscopic wrist surgery on Tuesday after being placed on the injured list on Sept. 24 with left wrist inflammation. The bigger revelation is what he had been dealing with behind the scenes: cysts that limited his mobility in the wrist joint for the past few months, including while he was still in Toronto.
That detail helps explain why Varsho’s production nosedived after a solid start. Through June 24, he had put together 31 runs scored, 15 doubles, two triples, seven home runs, 22 RBIs and seven stolen bases in 68 games. He was hitting .266, the best mark of his seven-year career, with a .778 OPS.
Then everything slipped. From there, Varsho hit .185 with a .515 OPS, adding 20 runs scored, eight doubles, five home runs and 18 RBIs.
After the Blue Jays dealt him to Houston, his numbers fell again: in 41 games with the Astros, he batted .172 with 12 runs scored, four doubles, five home runs and 14 RBIs. He was unavailable for Houston in the Wild Card series, and the Astros were swept out in two games by the Chicago White Sox.
For Toronto, getting any return for an ailing Varsho at the deadline now looks like a sharp bit of business. What comes next is still the bigger question.
The centerpiece of the return, pitcher Spencer Arrighetti, has not found his footing since the deal. Over seven appearances with the Blue Jays, he posted a 6.35 ERA and 1.54 WHIP with 19 strikeouts in 22.2 innings.
There’s still belief in him internally, though. The Blue Jays still seem to view Arrighetti as part of their long-term plans and will try to get him right over the winter. That hope comes from what he showed before the slump: Arrighetti was named American League Pitcher of the Month in May after going 4-1 in five starts with a 0.93 ERA.
June changed the tone fast. He gave up 25 earned runs that month and finished with a 9.00 ERA, which pushed his season mark to 4.94 before a trip to the IL with Morton's neuroma, a foot issue that causes nerve pain.
If Arrighetti gets back to full health and rediscovers that early-season form, this deal could still end up looking like a steal for Toronto. For now, though, that outcome is still a long way off.
In Other News...
Blue Jays Just Opened A Real Winter Debate At Second Base
Ross Atkins left little doubt that Ernie Clement has value to the Blue Jays, but he also made clear that value alone will not lock down a job two years from now. The Toronto general manager praised Clement as a versatile, impactful player, yet framed the second-base picture as something the club will keep evaluating as it looks for more dependable offense and a better overall fit around the roster.
That leaves the Blue Jays with a real winter conversation on their hands, even if the calendar has not quite gotten there yet. Second base and the outfield are both areas the front office wants to complement, and Atkins pointed to free agents and internal candidates as possible ways to do it, which suggests Clement will have to keep earning trust if he wants to remain the easy answer at the position. [Read more 🡒]
Kevin Gausman Just Reopened A Blue Jays Reunion Question
Kevin Gausmans brief run with the Cubs ended the way no pitcher wants, with a loss in Game 2 of the NL Wild Card series and Chicago out of the postseason. The former Blue Jays right-hander, acquired at the trade deadline and now in the final year of his contract, left the night sounding reflective enough to make the next step feel like more than just a formality.
For Toronto, it is enough to reopen a familiar question about whether Gausman could wind up back where he started the year. Nothing has been decided yet, but his emotional postgame interview only added fuel to the idea that his situation may not be settled, and the Blue Jays will be watching closely as the offseason starts to take shape. [Read more 🡒]
Blue Jays Face Two Offseason Questions That Could Shape Everything
The Blue Jays are heading into an offseason that could feel decisive before spring training even opens. After a year in which the roster still left room for more stability, the biggest needs are clear enough: strengthen the starting rotation and add more certainty in the outfield. Toronto does not need a wholesale rebuild, but it does need impact additions, and the market offers a few names that could help immediately.
Kevin Gausman and Shota Imanaga stand out as the starting-pitching possibilities, while Seiya Suzuki, Trevor Rogers and Randy Arozarena are among the outfield options worth tracking. The fit questions are different for each player, but the broader aim is simple for Toronto: find one reliable starter and one proven outfielder who can raise the floor of the roster. Whether the front office can line up those pieces will go a long way toward shaping how competitive this team looks next season. [Read more 🡒]